INTERNATIONAL ORTHOPAEDICS-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2022-05-01 146f3421m19(暂无昵称)

审稿速度:12.0
偏重的研究方向：骨科创伤;骨科临床研究
经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。

68 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-06-08 南方一刀

审稿速度:2.0 | 投稿命中率:25.0
经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用

130 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2020-07-03 drbob

审稿速度:1.0 | 投稿命中率:25.0
经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!#脊柱#但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒

4 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

什么是SCI？

57 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-09-25 ms3000000534700024

审稿速度:2.0
偏重的研究方向：骨科
经验分享：投稿不到两月，目前已接收

87 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2022-03-10 ms4000000490604277

杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！

61 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2018-06-19 老时

4月27日submit
6月3日minor revision
6月19日final decision accept
挺快的，哪位老师知道，我什么时候才能收到proof的连接？

262 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2018-04-16 Midaniel

审稿速度:3.0 | 投稿命中率:50.0
经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!

277 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2021-05-13 147818b7m56暂无昵称

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：骨科临床研究 ; 骨科
经验分享：投稿半个月，目前已经接收

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1216082, encodeId=43c8121608244, content=审稿速度:12.0 偏重的研究方向：骨科创伤;骨科临床研究 经验分享：一审9个月，差点撤稿；Major Revision两个月后accept，提出的问题相对简单。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a5935179494, createdName=146f3421m19(暂无昵称), createdTime=Sun May 01 16:36:26 CST 2022, time=2022-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601798, encodeId=ea04601e9857, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：投稿到一审结束一个月，大修后录用，对创新性要求比较高，最好对临床有一定指导意义的文章容易录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b78f1736747, createdName=南方一刀, createdTime=Mon Jun 08 13:24:15 CST 2020, time=2020-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=801061, encodeId=493180106181, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：sicot的官方杂志，2019的if也是猛涨，但是命中率狠低，但是审稿速度很快，可以尝试!<a href='/topic/show?id=3b1484506af' target=_blank style='color:#2F92EE;'>#脊柱#</a>但是对脊柱的文章需求量很少，真的真的太难中了，投了腰椎的和meta各一篇，都因为栏目不合适被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=5, topicName=null, topicId=null, topicList=[TopicDto(id=84506, encryptionId=3b1484506af, topicName=脊柱)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201226/ffbd7ae7f19a46d4bc76eadb164c5760/b3d082253d45492c9aa02bec640eb0af.jpg, createdBy=52185311019, createdName=drbob, createdTime=Fri Jul 03 11:54:53 CST 2020, time=2020-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092120, encodeId=20af109212061, content=什么是SCI？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1054663, encodeId=ffe2105466344, content=审稿速度:2.0 偏重的研究方向：骨科 经验分享：投稿不到两月，目前已接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acb5534074, createdName=ms3000000534700024, createdTime=Sat Sep 25 10:22:07 CST 2021, time=2021-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1201158, encodeId=f44c120115812, content=杂志让我大修，但是我没有看到审稿人的意见，请问在哪里可以找到审稿人的意见。谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=61, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c9535709916, createdName=ms4000000490604277, createdTime=Thu Mar 10 09:26:53 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558103, encodeId=21b25581031e, content=4月27日submit 6月3日minor revision 6月19日final decision accept 挺快的，哪位老师知道，我什么时候才能收到proof的连接？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=262, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/OUyyGOPy0mM0ibLLxiccOYeFdnmeZ4e2wHZzhia9yQGb1NalRFoQdokXjW9EOd5EEKyBxDibrfOgmA6uibTvE937MPA/132, createdBy=9c5c1768279, createdName=老时, createdTime=Tue Jun 19 19:21:00 CST 2018, time=2018-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=555066, encodeId=a3155550668c, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：D+0 new submission, D+2 editor assigned, D+32 revise before review(要求加2 reference), D+32 revision submission, D+36 reviewers assigned, D+38 under review, D+43 reviewers assigned, D+45 reviewers assigned , D+76 直接accept!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=92ec2265994, createdName=Midaniel, createdTime=Mon Apr 16 21:49:00 CST 2018, time=2018-04-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=965334, encodeId=549296533478, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：骨科临床研究 ; 骨科 经验分享：投稿半个月，目前已经接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9e165222307, createdName=147818b7m56暂无昵称, createdTime=Thu May 13 21:30:24 CST 2021, time=2021-05-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578510, encodeId=2e2a5e8510b5, content=同问，这个命中率怎样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

同问，这个命中率怎样

136 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务